Latest Insider Transactions at Clarus Therapeutics Holdings, Inc. (CRXT)
This section provides a real-time view of insider transactions for Clarus Therapeutics Holdings, Inc. (CRXT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Clarus Therapeutics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Clarus Therapeutics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2022
|
Elizabeth Cermak Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+25.0%
|
-
|
|
Jun 07
2022
|
Joseph Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+0.15%
|
-
|
|
Jun 07
2022
|
John Kenneth Amory Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+25.0%
|
-
|
|
Jun 07
2022
|
Kimberly M Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+25.0%
|
-
|
|
Jun 07
2022
|
Mark A Sr Prygocki Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+25.0%
|
-
|
|
Apr 25
2022
|
Joseph Hernandez Director |
BUY
Other acquisition or disposition
|
Direct |
1,237,500
+49.92%
|
-
|
|
Apr 25
2022
|
Joseph Hernandez Director |
SELL
Other acquisition or disposition
|
Indirect |
65,000
-4.99%
|
-
|
|
Dec 12
2021
|
Kimberly M Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,844
+50.0%
|
-
|
|
Dec 12
2021
|
Joseph Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,844
+50.0%
|
-
|
|
Dec 12
2021
|
Robert E. Dudley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
135,000
+49.17%
|
-
|
|
Dec 12
2021
|
John Kenneth Amory Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,844
+50.0%
|
-
|
|
Dec 12
2021
|
Elizabeth Cermak Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,844
+50.0%
|
-
|
|
Dec 12
2021
|
Mark A Sr Prygocki Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,844
+50.0%
|
-
|
|
Dec 11
2021
|
Steven A. Bourne Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,000
+48.9%
|
-
|
|
Dec 11
2021
|
Richard D Peterson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,800
+50.0%
|
-
|
|
Dec 11
2021
|
Frank Jaeger Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,000
+50.0%
|
-
|
|
Sep 17
2021
|
Ffi Fund LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
127,360
-5.71%
|
$1,146,240
$9.2 P/Share
|
|
Sep 09
2021
|
H.I.G. Ventures Clarus, LLC > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
5,692,381
+50.0%
|
-
|
|
Sep 09
2021
|
Steven A. Bourne Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,305
+50.0%
|
-
|
|
Sep 09
2021
|
Robert E. Dudley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,566
+50.0%
|
-
|
|
Sep 09
2021
|
Alex Zisson Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,692,381
+42.05%
|
-
|